stockaxis

Allchem Lifescience Ltd.

IPO Details
  • Issue Type Book building
  • Price range
  • Market Lot
  • Total Equity Shares
  • Face Value Rs. 10
  • Listing Date
IPO Timeline
Opening date
Closing date
Listing Date

IPO Details

Our Company is an Indian manufacturer of active pharmaceutical ingredients (API) intermediates and specialitychemicals. We specialise in the production of key starting materials (KSMs), generic API intermediates andspecialty chemicals.According to the CARE Report, with a reaction volume of 1,134 KL as of December 2024 and a hydrogenationcapacity of 60 KL, making it one of the largest in India, we are a key player in manufacturing derivatives ofpiperazine. According to the CARE Report, piperazine derivatives are critical raw materials for producing APIslike Quetiapine. In addition to a strong domestic customer base, we have also developed a significant exportmarket. One of our Promoters, Bipin Patel, began his business journey in 2003 under a proprietorship firm by thename of Allchem Laboratories (Proprietorship). In 2017, our Company acquired the existing business of the soleproprietorship of Bipin Patel viz., M/s Allchem Laboratories.

Projects

1. Project Name: Repayment or pre-payment, in full or in part, of certain of

Project Cost: 1300

Promoters

Prmoters Name

1. Bipin Patel

2. Kantilal Ramanlal Patel

3. Aditi Patel

4. Manisha Bipin Patel

Prmoters Holdings
  • Pre Share Capital: 76539780
  • Pre Promoter Holding: 100
  • Offer to Public:
  • Post Share Capital:
  • Post Promoter Holding:

Registrar

Registrar Name:Link Intime India Pvt Ltd.
Phone: 91-022-25946970/71/72/73/74/75/76/77/78/60320
Email: helpdesk@linkintime.co.in
Website: www.linkintime.co.in

Lead Managers

  • Emkay Global Financial Services Ltd

Subscription Details